Intimal Hyperplasia and Expression of Transforming Growth Factor-β1 in Saphenous Veins and Internal Mammary Arteries Before Coronary Artery Surgery
- 1 October 2004
- journal article
- research article
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 78 (4) , 1312-1318
- https://doi.org/10.1016/j.athoracsur.2004.02.066
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Histology and morphology of 59 internal thoracic artery grafts and their distal anastomosesThe Annals of Thoracic Surgery, 2000
- Increased Flow and Shear Stress Enhance In Vivo Transforming Growth Factor-β1 After Experimental Arterial InjuryArteriosclerosis, Thrombosis, and Vascular Biology, 2000
- Aortocoronary Saphenous Vein Graft DiseaseCirculation, 1998
- Modulation of Growth Factor ActionCirculation, 1997
- Coronary bypass graft fate and patient outcome: Angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 yearsJournal of the American College of Cardiology, 1996
- In Vivo Effect of TGF-β1Arteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Foam cell replication and smooth muscle cell apoptosis in human saphenous vein graftsHistopathology, 1994
- Antibodies against transforming growth factor-beta 1 suppress intimal hyperplasia in a rat model.Journal of Clinical Investigation, 1994
- A comparison of morphologic and angiographic findings in long-term internal mammary artery and saphenous vein bypass graftsJournal of the American College of Cardiology, 1988
- Influence of the Internal-Mammary-Artery Graft on 10-Year Survival and Other Cardiac EventsNew England Journal of Medicine, 1986